X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15139) 15139
Book Review (3066) 3066
Publication (1012) 1012
Conference Proceeding (54) 54
Book Chapter (42) 42
Magazine Article (15) 15
Dissertation (11) 11
Book / eBook (8) 8
Data Set (2) 2
Paper (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14353) 14353
humans (10367) 10367
male (6552) 6552
animals (6172) 6172
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5486) 5486
female (4554) 4554
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (4437) 4437
statins (4437) 4437
middle aged (3191) 3191
cholesterol (3103) 3103
hydroxymethylglutaryl coa reductases - metabolism (2686) 2686
rats (2652) 2652
aged (2435) 2435
pharmacology & pharmacy (2348) 2348
simvastatin (2280) 2280
adult (1922) 1922
cardiac & cardiovascular systems (1781) 1781
risk factors (1758) 1758
atorvastatin (1741) 1741
biochemistry & molecular biology (1635) 1635
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1572) 1572
atherosclerosis (1539) 1539
mice (1538) 1538
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1444) 1444
peripheral vascular disease (1433) 1433
abridged index medicus (1423) 1423
atorvastatin calcium (1422) 1422
cholesterol - metabolism (1400) 1400
treatment outcome (1352) 1352
lipids (1348) 1348
cholesterol - blood (1334) 1334
cholesterol, ldl - blood (1296) 1296
cells, cultured (1228) 1228
pravastatin (1227) 1227
hmg-coa reductase (1201) 1201
hydroxymethylglutaryl-coa reductase inhibitors (1116) 1116
liver - metabolism (1101) 1101
simvastatin - pharmacology (1085) 1085
hypercholesterolemia - drug therapy (1082) 1082
endocrinology & metabolism (1079) 1079
hypercholesterolemia (1077) 1077
dose-response relationship, drug (1057) 1057
statin (1051) 1051
analysis (1048) 1048
coronary-heart-disease (1029) 1029
risk (1015) 1015
inflammation (963) 963
hydroxymethylglutaryl coa reductases - genetics (948) 948
expression (944) 944
metabolism (937) 937
research (930) 930
time factors (915) 915
cholesterol - biosynthesis (879) 879
lipids - blood (875) 875
cardiovascular disease (868) 868
coenzyme-a reductase (860) 860
lovastatin - pharmacology (829) 829
prevention (829) 829
c-reactive protein (819) 819
coa reductase inhibitors (813) 813
therapy (813) 813
anticholesteremic agents - therapeutic use (799) 799
lovastatin (786) 786
enzymes (785) 785
cardiovascular-disease (778) 778
triglycerides - blood (773) 773
drug therapy (771) 771
disease (770) 770
heptanoic acids - pharmacology (768) 768
cardiovascular diseases - prevention & control (762) 762
physiological aspects (762) 762
drug therapy, combination (756) 756
pyrroles - pharmacology (751) 751
antilipemic agents (731) 731
care and treatment (721) 721
rats, sprague-dawley (719) 719
oxidative stress (705) 705
low density lipoproteins (702) 702
rosuvastatin calcium (698) 698
liver - drug effects (697) 697
medicine & public health (692) 692
medicine, general & internal (692) 692
low-density-lipoprotein (683) 683
cardiovascular (675) 675
drug interactions (674) 674
cell line (668) 668
rosuvastatin (668) 668
diabetes (661) 661
rna, messenger - metabolism (652) 652
health aspects (650) 650
heptanoic acids - therapeutic use (650) 650
disease models, animal (649) 649
liver - enzymology (647) 647
cardiovascular diseases (645) 645
liver (645) 645
nitric-oxide synthase (645) 645
pyrroles - therapeutic use (645) 645
cholesterol, hdl - blood (637) 637
kinetics (631) 631
in-vitro (622) 622
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14640) 14640
Japanese (100) 100
Russian (76) 76
Chinese (55) 55
German (51) 51
French (48) 48
Spanish (48) 48
Hungarian (34) 34
Polish (30) 30
Czech (18) 18
Italian (18) 18
Portuguese (12) 12
Dutch (11) 11
Norwegian (7) 7
Ukrainian (5) 5
Korean (4) 4
Swedish (4) 4
Danish (3) 3
Finnish (3) 3
Hebrew (3) 3
Turkish (3) 3
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Metabolism, ISSN 1550-4131, 05/2012, Volume 15, Issue 5, pp. 665 - 674
Nonalcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular and liver-related mortality. NAFLD is characterized by both triglyceride... 
RAT-LIVER | RISK-FACTORS | MACROPHAGE APOPTOSIS | PROTEIN-KINASE | ENDOCRINOLOGY & METABOLISM | HMG-COA REDUCTASE | STEATOHEPATITIS | 3-HYDROXY-3-METHYLGLUTARYL COENZYME | PREVALENCE | MICRORNA EXPRESSION | MODULATION | CELL BIOLOGY | Sirtuin 1 - metabolism | Up-Regulation | Cholesterol - blood | Humans | Middle Aged | Sterol Esterase - metabolism | Male | MicroRNAs - metabolism | Desmosterol - metabolism | Cardiovascular Diseases - genetics | Cholesterol - genetics | Sirtuin 1 - genetics | Case-Control Studies | Phosphorylation - genetics | Hydroxymethylglutaryl CoA Reductases - metabolism | Adenylate Kinase - metabolism | Non-alcoholic Fatty Liver Disease | Sterol O-Acyltransferase - metabolism | Adult | Female | Lipid Metabolism - genetics | Sterol Regulatory Element Binding Protein 2 - genetics | Sterol Regulatory Element Binding Protein 2 - metabolism | Fatty Liver - genetics | Receptors, LDL - genetics | Gene Expression | Fatty Liver - metabolism | Cardiovascular Diseases - metabolism | Fatty Liver - blood | Liver - metabolism | Receptors, LDL - metabolism | Cholesterol - metabolism | Cholesterol, LDL - genetics | Phenotype | Sterol Esterase - genetics | Desmosterol - blood | Cholesterol, LDL - metabolism | MicroRNAs - genetics | Sterol O-Acyltransferase - genetics | Adenylate Kinase - genetics | Hydroxymethylglutaryl CoA Reductases - genetics | Enzymes | Liver diseases | Low density lipoproteins | Genes | Esters | Triglycerides | Cholesterol | MicroRNA | Fatty liver | Blood cholesterol | Physiological aspects | Hydrolases | Blood lipids | Health aspects | Statins | Index Medicus | atherosclerosis | Nonalcoholic steatohepatitis | cholesterol | Nonalcoholic fatty liver disease | fatty liver | lipogenesis | hypercholesterolemia | HMG CoA reductase
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2013, Volume 138, Issue 2, pp. 499 - 508
Journal Article
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2016, Volume 99, pp. 35 - 46
Journal Article
Journal Article
Journal of Food Science, ISSN 0022-1147, 11/2017, Volume 82, Issue 11, pp. 2700 - 2705
GINST, a hydrolyzed ginseng extract, has been reported to have antidiabetic effects and to reduce hyperglycemia and hyperlipidemia. Hypercholesterolemia is... 
cholesterol | HMG‐CoA reductase | IH‐901 | AMP‐activated protein kinase α | GINST | IH-901 | AMP-activated protein kinase α | HMG-CoA reductase | AMP-Activated Protein Kinases - metabolism | Signal Transduction | Plant Extracts - pharmacology | Humans | Ginsenosides - pharmacology | Hepatocytes - metabolism | PPAR gamma - metabolism | Hep G2 Cells | Hydroxymethylglutaryl CoA Reductases - metabolism | Panax - chemistry | Sterol Regulatory Element Binding Protein 2 - genetics | Phosphorylation - drug effects | Sterol Regulatory Element Binding Protein 2 - metabolism | Cholesterol - biosynthesis | Hydroxymethylglutaryl CoA Reductases - genetics | AMP-Activated Protein Kinases - genetics | Hepatocytes - drug effects | Hepatocytes - enzymology | PPAR gamma - genetics | Genetic aspects | Ginseng | Gene expression | Protein kinases | Health aspects | Cholesterol | TOR protein | Phosphorylation | Liver | Cardiovascular disease | AKT protein | Activation | CCAAT/enhancer-binding protein | Kinases | AMP-activated protein kinase | Proteins | Signal transduction | Hyperglycemia | Synthesis | Atherosclerosis | Sterol regulatory element-binding protein | Genetic factors | Heart diseases | AMP | Hyperlipidemia | Diabetes mellitus | Rapamycin | Coronary artery disease | Biological activity | Hypercholesterolemia | Hepatocytes | Arteriosclerosis | Atorvastatin | Hydroxymethylglutaryl-CoA reductase | Glyceraldehyde-3-phosphate dehydrogenase | Transduction | Peroxisome proliferator-activated receptors | Cardiovascular diseases | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 03/2011, Volume 71, Issue 6, pp. 2286 - 2297
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2010, Volume 107, Issue 34, pp. 15051 - 15056
The importance of cancer metabolism has been appreciated for many years, but the intricacies of how metabolic pathways interconnect with oncogenic signaling... 
Hep G2 cells | Research fellowships | Cell growth | Messenger RNA | Cellular metabolism | Prognosis | Cell cycle | Breast cancer | Cancer | Tumors | Tumor metabolism | Hydroxymethylglutaryl coenzyme A reductase | HMGCR | Metabolic oncogene | MULTIPLE-MYELOMA | CELLS | hydroxymethylglutaryl coenzyme A reductase | MULTIDISCIPLINARY SCIENCES | HMG-COA REDUCTASE | STATIN USE | LOVASTATIN-INDUCED APOPTOSIS | SIGNATURE | NEGATIVE BREAST-CANCER | METABOLISM | metabolic oncogene | GENE-EXPRESSION | cancer | INHIBITORS | tumor metabolism | Neoplasm Transplantation | Alternative Splicing | Humans | Gene Expression Regulation, Neoplastic | Male | Transplantation, Heterologous | DNA Primers - genetics | RNA, Messenger - metabolism | RNA, Neoplasm - metabolism | Breast Neoplasms - metabolism | Hydroxymethylglutaryl CoA Reductases - metabolism | Cell Transformation, Neoplastic - genetics | Base Sequence | Female | RNA, Messenger - genetics | Mevalonic Acid - metabolism | Mice, SCID | Cell Transformation, Neoplastic - metabolism | Gene Expression Regulation, Enzymologic | Animals | Breast Neoplasms - genetics | Cell Line, Tumor | RNA, Neoplasm - genetics | Mice | Hydroxymethylglutaryl CoA Reductases - genetics | Cell metabolism | Health aspects | Mevalonate | Enzymes | Rodents | Oncology | Biochemistry | Physiology | Metabolism | Gene expression | Index Medicus | Biological Sciences
Journal Article
Journal Article